【justin1999031】評論

stroke那欄專指體動脈栓塞，不包含PE, DVT。The confusion within this component of the CHA2DS2-VASc score comes from the inclusion of TE. There are several areas within the original validation trial that would infer thatdeep vein thrombosis (DVT) or pulmonary embolism (PE) would be included within the score1. A key point in clarifying this component is to define “systemic embolism”. The term“systemic” implies that the clot develops in the left-side of the heart and the embolism will be pushed “systemically” or via the arteries. Specifically, the ARISTOTLE trial defined systemic embolism as requiring “a clinical history consistent with an acute loss of blood flow to a peripheral artery (or arteries) supported by the evidence of embolism from surgicalspecimens, autopsy, angiography, vascular imaging, or other objective testing.”4 By these definitions, DVT and PE would not be included within the CHA2DS2-VASc score; however,a DVT and/or PE identifies a high-risk population for recurrent embolisms and might need to be evaluated independently in clinical decisions within anticoagulation therapy8https://meddataspeaks.wordpress.com/2014/09/04/%E8%87%A8%E5%BA%8A%E8%97%A5%E5%AD%B8-cha2ds2-vasc-score%E5%92%8C-has-bled-score/.